Michael Fanselow, distinguished professor of psychology (UCLA Life Sciences) and psychiatry & biobehavioral sciences (David Geffen School of Medicine), led a study focusing on the connection between traumatic brain injuries and anxiety disorders, such as post-traumatic stress disorder (PTSD). The study was published in Scientific Reports, a sub journal of Nature.
Read more →
In a recent press release by MDedge Psychiatry – an online journalism resource – Katherine Narr, associate professor of neurology and psychiatry and biobehavioral sciences at the David Geffen School of Medicine, discussed the results from a study performed as part of the Depression Grand Challenge’s Serial Ketamine Infusion Biomarkers demonstration project.
Read more →
Depression doesn’t look the same among all individuals that live with depression. Some people have a type of depression that is resistant to medication and more difficult to treat. Researchers at UCLA have shown that individuals with higher levels of inflammation and treatment resistant depression may benefit from Read more →
Current UCLA Students are invited to Participate in the internet-based cognitive behavioral therapy (iCBT) StudyUCLA is currently recruiting students for an iCBT Study as part of the Depression Grand Challenge (DGC) campus initiative. The iCBT Student Study is the first attempt by the DGC to implement a tiered treatment plan for depressed individuals dependent on severity of symptoms of depression or anxiety. Using an initial online screening tool, participants will be Read more →
UCLA researchers have discovered a new drug that could help people overcome alcoholism. Participants taking the medication, ibudilast, experienced significantly lower cravings for alcohol than when taking the placebo. Not only did ibudilast dampen alcohol cravings, but it also improved participants’ moods after being shown their preferred alcoholic beverage. Researchers also found Read more →